NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
1-Year Return
24.46%
This Quarter Return
+16.38%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$8.08B
AUM Growth
+$2.81B
(+53%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
26.98%
Top 10 Holdings %
Top 10 Hldgs %
37.62%
Holding
626
New
29
Increased
519
Reduced
46
Closed
10
Top Buys
| 1 |
NVIDIA
NVDA
|
$166M |
| 2 |
Microsoft
MSFT
|
$162M |
| 3 |
Apple
AAPL
|
$126M |
| 4 |
Broadcom
AVGO
|
$86.4M |
| 5 |
Amazon
AMZN
|
$85.6M |
Top Sells
| 1 |
Clean Harbors
CLH
|
$4.34M |
| 2 |
Rockwell Automation
ROK
|
$4.29M |
| 3 |
Vulcan Materials
VMC
|
$4.24M |
| 4 |
Applied Industrial Technologies
AIT
|
$3.95M |
| 5 |
ATI
ATI
|
$3.93M |
Sector Composition
| 1 | Technology | 37.54% |
| 2 | Communication Services | 11.03% |
| 3 | Consumer Discretionary | 10.09% |
| 4 | Healthcare | 8.06% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Cousins Properties
CUZ
$4.92B
| $239K | ﹤0.01% |
+7,961
| New | +$239K |
|
602
Factset
FDS
$13.9B
| $235K | ﹤0.01% |
526
| – | – |
|
603
Ferrari
RACE
$88.4B
| $230K | ﹤0.01% |
469
| – | – |
|
604
Snap-on
SNA
$17.1B
| $229K | ﹤0.01% |
735
+4
| +0.5% | +$1.25K |
|
605
Acadia Pharmaceuticals
ACAD
$4.31B
| $229K | ﹤0.01% |
10,596
| – | – |
|
606
Celcuity
CELC
$2.3B
| $227K | ﹤0.01% |
17,011
+1,392
| +9% | +$18.6K |
|
607
Intellia Therapeutics
NTLA
$1.23B
| $226K | ﹤0.01% |
24,053
-2,484
| -9% | -$23.3K |
|
608
Zebra Technologies
ZBRA
$15.7B
| $219K | ﹤0.01% |
+711
| New | +$219K |
|
609
Domino's
DPZ
$15.5B
| $218K | ﹤0.01% |
484
| – | – |
|
610
Denali Therapeutics
DNLI
$2.16B
| $212K | ﹤0.01% |
15,174
| – | – |
|
611
Sabra Healthcare REIT
SBRA
$4.55B
| $207K | ﹤0.01% |
+11,219
| New | +$207K |
|
612
Americold
COLD
$3.92B
| $207K | ﹤0.01% |
+12,423
| New | +$207K |
|
613
Everest Group
EG
$14.6B
| $204K | ﹤0.01% |
601
| – | – |
|
614
Rocket Pharmaceuticals
RCKT
$345M
| $78.5K | ﹤0.01% |
32,030
-4,833
| -13% | -$11.8K |
|
615
Talkspace
TALK
$442M
| $77.4K | ﹤0.01% |
27,834
| – | – |
|
616
Voyager Therapeutics
VYGR
$204M
| $46.5K | ﹤0.01% |
14,960
| – | – |
|
|
BPMC
617
DELISTED
Blueprint Medicines
BPMC
| – | – |
-20,972
| Closed | -$1.86M |
|
618
Donaldson
DCI
$9.34B
| – | – |
-11,848
| Closed | -$795K |
|
|
DFS
619
DELISTED
Discover Financial Services
DFS
| – | – |
-17,848
| Closed | -$3.05M |
|
620
Jazz Pharmaceuticals
JAZZ
$7.85B
| – | – |
-1,672
| Closed | -$208K |
|
621
Lantheus
LNTH
$3.69B
| – | – |
-4,329
| Closed | -$423K |
|
622
MongoDB
MDB
$25.7B
| – | – |
-4,467
| Closed | -$784K |
|
623
Oric Pharmaceuticals
ORIC
$1.01B
| – | – |
-40,934
| Closed | -$228K |
|
624
WESCO International
WCC
$10.6B
| – | – |
-24,991
| Closed | -$3.88M |
|
625
Xenon Pharmaceuticals
XENE
$2.95B
| – | – |
-6,111
| Closed | -$205K |
|